Update shared on29 Aug 2025
Fair value Decreased 2.24%Analysts have lowered LANXESS's price target to €26.79, citing ongoing operational headwinds, margin pressure, and delayed recovery in key markets, while acknowledging that cost measures will take time to improve earnings.
Analyst Commentary
- Bearish analysts cite persistent near-term operational headwinds and sluggish demand as reasons for lowering price targets.
- Concerns remain over margin pressure due to increased input costs and limited pricing power.
- The absence of clear recovery signals in key end markets has contributed to tempered expectations.
- Cost restructuring measures are expected to take time to positively impact earnings.
- Despite reduced targets, some bullish analysts continue to see long-term upside potential, maintaining overweight ratings based on anticipated structural improvements.
Valuation Changes
Summary of Valuation Changes for LANXESS
- The Consensus Analyst Price Target has fallen slightly from €27.40 to €26.79.
- The Net Profit Margin for LANXESS has significantly risen from 0.07% to 0.17%.
- The Future P/E for LANXESS has significantly fallen from 645.77x to 252.18x.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.